Copyright Reports & Markets. All rights reserved.

Global Gastrointestinal Cancer Treatment Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gastrointestinal Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Surgery
    • 1.2.3 Targeted Drugs Therapy
    • 1.2.4 Chemo Therapy
    • 1.2.5 Adjuvant Chemotherapy
    • 1.2.6 Radiation Therapy
  • 1.3 Market by Application
    • 1.3.1 Global Gastrointestinal Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Research Centers
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastrointestinal Cancer Treatment Market Perspective (2016-2027)
  • 2.2 Gastrointestinal Cancer Treatment Growth Trends by Regions
    • 2.2.1 Gastrointestinal Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Gastrointestinal Cancer Treatment Historic Market Share by Regions (2016-2021)
    • 2.2.3 Gastrointestinal Cancer Treatment Forecasted Market Size by Regions (2022-2027)
  • 2.3 Gastrointestinal Cancer Treatment Industry Dynamic
    • 2.3.1 Gastrointestinal Cancer Treatment Market Trends
    • 2.3.2 Gastrointestinal Cancer Treatment Market Drivers
    • 2.3.3 Gastrointestinal Cancer Treatment Market Challenges
    • 2.3.4 Gastrointestinal Cancer Treatment Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue
    • 3.1.1 Global Top Gastrointestinal Cancer Treatment Players by Revenue (2016-2021)
    • 3.1.2 Global Gastrointestinal Cancer Treatment Revenue Market Share by Players (2016-2021)
  • 3.2 Global Gastrointestinal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Gastrointestinal Cancer Treatment Revenue
  • 3.4 Global Gastrointestinal Cancer Treatment Market Concentration Ratio
    • 3.4.1 Global Gastrointestinal Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Cancer Treatment Revenue in 2020
  • 3.5 Gastrointestinal Cancer Treatment Key Players Head office and Area Served
  • 3.6 Key Players Gastrointestinal Cancer Treatment Product Solution and Service
  • 3.7 Date of Enter into Gastrointestinal Cancer Treatment Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Cancer Treatment Breakdown Data by Type

  • 4.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Type (2016-2021)
  • 4.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Gastrointestinal Cancer Treatment Breakdown Data by Application

  • 5.1 Global Gastrointestinal Cancer Treatment Historic Market Size by Application (2016-2021)
  • 5.2 Global Gastrointestinal Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Gastrointestinal Cancer Treatment Market Size (2016-2027)
  • 6.2 North America Gastrointestinal Cancer Treatment Market Size by Type
    • 6.2.1 North America Gastrointestinal Cancer Treatment Market Size by Type (2016-2021)
    • 6.2.2 North America Gastrointestinal Cancer Treatment Market Size by Type (2022-2027)
    • 6.2.3 North America Gastrointestinal Cancer Treatment Market Size by Type (2016-2027)
  • 6.3 North America Gastrointestinal Cancer Treatment Market Size by Application
    • 6.3.1 North America Gastrointestinal Cancer Treatment Market Size by Application (2016-2021)
    • 6.3.2 North America Gastrointestinal Cancer Treatment Market Size by Application (2022-2027)
    • 6.3.3 North America Gastrointestinal Cancer Treatment Market Size by Application (2016-2027)
  • 6.4 North America Gastrointestinal Cancer Treatment Market Size by Country
    • 6.4.1 North America Gastrointestinal Cancer Treatment Market Size by Country (2016-2021)
    • 6.4.2 North America Gastrointestinal Cancer Treatment Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.3 Canada

7 Europe

  • 7.1 Europe Gastrointestinal Cancer Treatment Market Size (2016-2027)
  • 7.2 Europe Gastrointestinal Cancer Treatment Market Size by Type
    • 7.2.1 Europe Gastrointestinal Cancer Treatment Market Size by Type (2016-2021)
    • 7.2.2 Europe Gastrointestinal Cancer Treatment Market Size by Type (2022-2027)
    • 7.2.3 Europe Gastrointestinal Cancer Treatment Market Size by Type (2016-2027)
  • 7.3 Europe Gastrointestinal Cancer Treatment Market Size by Application
    • 7.3.1 Europe Gastrointestinal Cancer Treatment Market Size by Application (2016-2021)
    • 7.3.2 Europe Gastrointestinal Cancer Treatment Market Size by Application (2022-2027)
    • 7.3.3 Europe Gastrointestinal Cancer Treatment Market Size by Application (2016-2027)
  • 7.4 Europe Gastrointestinal Cancer Treatment Market Size by Country
    • 7.4.1 Europe Gastrointestinal Cancer Treatment Market Size by Country (2016-2021)
    • 7.4.2 Europe Gastrointestinal Cancer Treatment Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size (2016-2027)
  • 8.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type
    • 8.2.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application
    • 8.3.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region
    • 8.4.1 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Gastrointestinal Cancer Treatment Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gastrointestinal Cancer Treatment Market Size (2016-2027)
  • 9.2 Latin America Gastrointestinal Cancer Treatment Market Size by Type
    • 9.2.1 Latin America Gastrointestinal Cancer Treatment Market Size by Type (2016-2021)
    • 9.2.2 Latin America Gastrointestinal Cancer Treatment Market Size by Type (2022-2027)
    • 9.2.3 Latin America Gastrointestinal Cancer Treatment Market Size by Type (2016-2027)
  • 9.3 Latin America Gastrointestinal Cancer Treatment Market Size by Application
    • 9.3.1 Latin America Gastrointestinal Cancer Treatment Market Size by Application (2016-2021)
    • 9.3.2 Latin America Gastrointestinal Cancer Treatment Market Size by Application (2022-2027)
    • 9.3.3 Latin America Gastrointestinal Cancer Treatment Market Size by Application (2016-2027)
  • 9.4 Latin America Gastrointestinal Cancer Treatment Market Size by Country
    • 9.4.1 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2016-2021)
    • 9.4.2 Latin America Gastrointestinal Cancer Treatment Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size (2016-2027)
  • 10.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type
    • 10.2.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application
    • 10.3.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country
    • 10.4.1 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Gastrointestinal Cancer Treatment Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Eli Lilly
    • 11.1.1 Eli Lilly Company Details
    • 11.1.2 Eli Lilly Business Overview
    • 11.1.3 Eli Lilly Gastrointestinal Cancer Treatment Introduction
    • 11.1.4 Eli Lilly Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.1.5 Eli Lilly Recent Development
  • 11.2 F. Hoffmann
    • 11.2.1 F. Hoffmann Company Details
    • 11.2.2 F. Hoffmann Business Overview
    • 11.2.3 F. Hoffmann Gastrointestinal Cancer Treatment Introduction
    • 11.2.4 F. Hoffmann Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.2.5 F. Hoffmann Recent Development
  • 11.3 GlaxoSmithKline
    • 11.3.1 GlaxoSmithKline Company Details
    • 11.3.2 GlaxoSmithKline Business Overview
    • 11.3.3 GlaxoSmithKline Gastrointestinal Cancer Treatment Introduction
    • 11.3.4 GlaxoSmithKline Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.3.5 GlaxoSmithKline Recent Development
  • 11.4 Merck
    • 11.4.1 Merck Company Details
    • 11.4.2 Merck Business Overview
    • 11.4.3 Merck Gastrointestinal Cancer Treatment Introduction
    • 11.4.4 Merck Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.4.5 Merck Recent Development
  • 11.5 Novartis AG
    • 11.5.1 Novartis AG Company Details
    • 11.5.2 Novartis AG Business Overview
    • 11.5.3 Novartis AG Gastrointestinal Cancer Treatment Introduction
    • 11.5.4 Novartis AG Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.5.5 Novartis AG Recent Development
  • 11.6 Otsuka Holdings
    • 11.6.1 Otsuka Holdings Company Details
    • 11.6.2 Otsuka Holdings Business Overview
    • 11.6.3 Otsuka Holdings Gastrointestinal Cancer Treatment Introduction
    • 11.6.4 Otsuka Holdings Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.6.5 Otsuka Holdings Recent Development
  • 11.7 Stryker Corporation
    • 11.7.1 Stryker Corporation Company Details
    • 11.7.2 Stryker Corporation Business Overview
    • 11.7.3 Stryker Corporation Gastrointestinal Cancer Treatment Introduction
    • 11.7.4 Stryker Corporation Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.7.5 Stryker Corporation Recent Development
  • 11.8 Boston Scientific Corporation
    • 11.8.1 Boston Scientific Corporation Company Details
    • 11.8.2 Boston Scientific Corporation Business Overview
    • 11.8.3 Boston Scientific Corporation Gastrointestinal Cancer Treatment Introduction
    • 11.8.4 Boston Scientific Corporation Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.8.5 Boston Scientific Corporation Recent Development
  • 11.9 Johnson and Johnson
    • 11.9.1 Johnson and Johnson Company Details
    • 11.9.2 Johnson and Johnson Business Overview
    • 11.9.3 Johnson and Johnson Gastrointestinal Cancer Treatment Introduction
    • 11.9.4 Johnson and Johnson Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.9.5 Johnson and Johnson Recent Development
  • 11.10 CONMED Corporation
    • 11.10.1 CONMED Corporation Company Details
    • 11.10.2 CONMED Corporation Business Overview
    • 11.10.3 CONMED Corporation Gastrointestinal Cancer Treatment Introduction
    • 11.10.4 CONMED Corporation Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.10.5 CONMED Corporation Recent Development
  • 11.11 Bristol-Myers Squibb
    • 11.11.1 Bristol-Myers Squibb Company Details
    • 11.11.2 Bristol-Myers Squibb Business Overview
    • 11.11.3 Bristol-Myers Squibb Gastrointestinal Cancer Treatment Introduction
    • 11.11.4 Bristol-Myers Squibb Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.11.5 Bristol-Myers Squibb Recent Development
  • 11.12 Pfizer
    • 11.12.1 Pfizer Company Details
    • 11.12.2 Pfizer Business Overview
    • 11.12.3 Pfizer Gastrointestinal Cancer Treatment Introduction
    • 11.12.4 Pfizer Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.12.5 Pfizer Recent Development
  • 11.13 Celltrion Inc
    • 11.13.1 Celltrion Inc Company Details
    • 11.13.2 Celltrion Inc Business Overview
    • 11.13.3 Celltrion Inc Gastrointestinal Cancer Treatment Introduction
    • 11.13.4 Celltrion Inc Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.13.5 Celltrion Inc Recent Development
  • 11.14 Amgen Limited
    • 11.14.1 Amgen Limited Company Details
    • 11.14.2 Amgen Limited Business Overview
    • 11.14.3 Amgen Limited Gastrointestinal Cancer Treatment Introduction
    • 11.14.4 Amgen Limited Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.14.5 Amgen Limited Recent Development
  • 11.15 Celgene Corporation
    • 11.15.1 Celgene Corporation Company Details
    • 11.15.2 Celgene Corporation Business Overview
    • 11.15.3 Celgene Corporation Gastrointestinal Cancer Treatment Introduction
    • 11.15.4 Celgene Corporation Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.15.5 Celgene Corporation Recent Development
  • 11.16 Sanofi
    • 11.16.1 Sanofi Company Details
    • 11.16.2 Sanofi Business Overview
    • 11.16.3 Sanofi Gastrointestinal Cancer Treatment Introduction
    • 11.16.4 Sanofi Revenue in Gastrointestinal Cancer Treatment Business (2016-2021)
    • 11.16.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Gastrointestinal Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Surgery
    Targeted Drugs Therapy
    Chemo Therapy
    Adjuvant Chemotherapy
    Radiation Therapy

    Segment by Application
    Hospitals
    Clinics
    Research Centers
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Eli Lilly
    F. Hoffmann
    GlaxoSmithKline
    Merck
    Novartis AG
    Otsuka Holdings
    Stryker Corporation
    Boston Scientific Corporation
    Johnson and Johnson
    Merck
    Novartis AG
    Pfizer
    Celltrion Inc
    Amgen Limited
    Celgene Corporation

    Buy now